Blog - Page 4053 of 5387

MondayNov 03, 2008 6:20 am

Unbridled Energy Corporation (TSX: UNE CN)

Unbridled Energy Corporation (TSX: UNE CN), an independent natural gas evaluation and production company, specializes in shale gas and tight gas sands opportunities in two main basins within North America. The company strategically applies a lower risk production enhancement strategy on existing wells, and the latest horizontal drilling and fracing technologies on new wells in well known shale gas and tight gas sands formations in the Appalachian Basin. For further information, visit the Company's web site at www.unbridledenergy.com.

MondayNov 03, 2008 6:20 am

TXCO Resources, Inc. (NASDAQ: TXCO)

TXCO Resources, Inc. (NASDAQ: TXCO), a full-cycle oil and gas exploration and production company, has a diversified exploitation, development and exploration project inventory. The company has more than 800,000 net acres under lease (1.3 million gross acres) and utilizes its geological and geophysical expertise to increase shareholder value. TXCO Resources applies new technology to overlooked opportunities in high-potential areas that offer multiple resource plays and thousands of drilling prospects. For further information, visit the Company's web site at www.txco.com.

MondayNov 03, 2008 6:20 am

Enable Holdings, Inc. (OTC BB: ENAB)

Enable Holdings, Inc. (OTC BB: ENAB), the world's leading excess inventory solutions company, is focused on linking brand name sellers with customers around the globe. The company does this through its multi-channel asset-recovery solution that includes an online auction platform located at www.ubid.com, upcoming fixed-price commerce solution RedTag.com, offline excess inventory solution RedTag Live!, business-to-business solution Dibu Trading Company, and upcoming private auction software company Commerce Innovations. For further information, visit the Company's web site at www.enableholdings.com.

MondayNov 03, 2008 6:19 am

Emisphere Technologies, Inc. (NASDAQ: EMIS)

Emisphere Technologies, Inc. (NASDAQ: EMIS), a biopharmaceutical company, is focused on utilizing its Eligen(r) Technology to uniquely deliver therapeutic molecules. Traditionally, these molecules are delivered by injection, and in many cases, are limited because of poor bioavailability, slow on-set of action or variable absorption. With Eligen(r) Technology, oral administration is possible as well other delivery pathways. For further information, visit the Company's web site at www.emisphere.com.

MondayNov 03, 2008 6:19 am

TUSK Energy Corporation (TSX: TSK CN)

TUSK Energy Corporation (TSX: TSK CN) is focused on the acquisition, exploration, development and production of oil and natural gas reserves in three focus areas in the northwestern part of the Western Canadian Sedimentary Basin. The company is currently developing natural gas in the Conroy area of northeastern British Columbia and light oil and natural gas in the Peace River Arch and Mega/Gutah areas of northern Alberta. For further information, visit the Company's web site at www.tusk-energy.com.

MondayNov 03, 2008 6:19 am

Trubion Pharmaceuticals, Inc. (NASDAQ: TRBN)

Trubion Pharmaceuticals, Inc. (NASDAQ: TRBN), a biopharmaceutical company, focuses its efforts on creating a pipeline of innovative protein therapeutic product candidates designed to treat autoimmune and inflammatory diseases and cancer. The company aims to develop an assortment of first-in-class and best-in-class products, customized for optimal safety, efficacy, and convenience. Trubion’s product development efforts are focused on three technology pillars that encompass the expanded foundation for Trubion product development. For further information, visit the Company's web site at www.trubion.com.

MondayNov 03, 2008 6:18 am

Emergent BioSolutions, Inc. (NYSE: EBS)

Emergent BioSolutions, Inc. (NYSE: EBS), a leading biopharmaceutical company, is focused on its mission to protect life. To achieve this goal, the company develops, manufactures, and commercializes immune related biologics, vaccines and biotherapeutics designed to support the body’s immune system to prevent or treat infectious and other life threatening diseases. Their broad product pipeline also includes: two “next generation” anthrax vaccines, two anthrax therapeutics (immunoglobulin and monoclonal), two botulinum vaccines and a botulinum therapeutic, an oral typhoid vaccine, a next generation tuberculosis vaccine, a hepatitis B immunotherapy, and a chlamydia vaccine. For further information, visit the Company's web site at…

MondayNov 03, 2008 6:18 am

Transgenomic, Inc. (OTC BB: TBIO)

Transgenomic, Inc. (OTC BB: TBIO), a global biotechnology company, is focused on providing novel products and services for automated high sensitivity genetic variation and mutation analysis. The company’s offerings currently include systems, products, discovery and laboratory testing services that find application in the academic and medical research, clinical laboratory and pharmaceutical markets in the fields of pharmacogenomics and personalized medicine. For further information, visit the Company's web site at www.transgenomic.com.

MondayNov 03, 2008 6:18 am

eFuture Information Technology, Inc. (NASDAQ:EFUT)

eFuture Information Technology, Inc. (NASDAQ: EFUT) is focused on applying advanced technology, valuable professional service and best practices to help clients purge inefficiencies and ineffectiveness in business. The company’s clients are centered in the retail, automotive, general household appliance and consumer goods industries. e-Future currently provides software products and services to more than 800 clients. For further information, visit the Company's web site at www.e-future.com.cn.

MondayNov 03, 2008 6:17 am

Transdel Pharmaceuticals, Inc. (OTC BB: TDLP)

Transdel Pharmaceuticals, Inc. (OTC BB: TDLP), a specialty pharmaceutical company, is dedicated to developing and commercializing non-invasive topically delivered medications. Ketotransdel, Transdel’s lead topical drug, leverages the company’s proprietary Transdel™ cream formulation to facilitate the passage of ketoprofen through the skin to reach underlying tissue where the drug exerts its prolonged localized anti-inflammatory and analgesic effect. For further information, visit the Company's web site at www.transdelpharma.com.

Site Search

Company Search

Unbridled Energy Corporation (TSX: UNE CN)

TXCO Resources, Inc. (NASDAQ: TXCO)

Enable Holdings, Inc. (OTC BB: ENAB)

Emisphere Technologies, Inc. (NASDAQ: EMIS)

TUSK Energy Corporation (TSX: TSK CN)

Trubion Pharmaceuticals, Inc. (NASDAQ: TRBN)

Emergent BioSolutions, Inc. (NYSE: EBS)

Transgenomic, Inc. (OTC BB: TBIO)

eFuture Information Technology, Inc. (NASDAQ:EFUT)

Transdel Pharmaceuticals, Inc. (OTC BB: TDLP)

Market Basics

Newsletter Publishers

Public Companies